332 related articles for article (PubMed ID: 18544674)
21. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
22. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
Nakagawa Y; Nakamura M; McIntosh TK; Rodriguez A; Berlin JA; Smith DH; Saatman KE; Raghupathi R; Clemens J; Saido TC; Schmidt ML; Lee VM; Trojanowski JQ
J Comp Neurol; 1999 Aug; 411(3):390-8. PubMed ID: 10413774
[TBL] [Abstract][Full Text] [Related]
23. Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse.
Nakajima A; Aoyama Y; Nguyen TT; Shin EJ; Kim HC; Yamada S; Nakai T; Nagai T; Yokosuka A; Mimaki Y; Ohizumi Y; Yamada K
Behav Brain Res; 2013 Aug; 250():351-60. PubMed ID: 23714077
[TBL] [Abstract][Full Text] [Related]
24. Abeta N-terminal-end specific antibody reduced beta-amyloid in Alzheimer-model mice.
Horikoshi Y; Mori T; Maeda M; Kinoshita N; Sato K; Yamaguchi H
Biochem Biophys Res Commun; 2004 Dec; 325(2):384-7. PubMed ID: 15530403
[TBL] [Abstract][Full Text] [Related]
25. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
[TBL] [Abstract][Full Text] [Related]
26. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
27. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
[TBL] [Abstract][Full Text] [Related]
28. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN
Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242
[TBL] [Abstract][Full Text] [Related]
29. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
Dodart JC; Bales KR; Gannon KS; Greene SJ; DeMattos RB; Mathis C; DeLong CA; Wu S; Wu X; Holtzman DM; Paul SM
Nat Neurosci; 2002 May; 5(5):452-7. PubMed ID: 11941374
[TBL] [Abstract][Full Text] [Related]
30. A novel approach for studying endogenous abeta processing using cultured primary neurons isolated from APP transgenic mice.
Qiu Z; Naten DL; Liston JC; Yess J; Rebeck GW
Exp Neurol; 2001 Jul; 170(1):186-94. PubMed ID: 11421596
[TBL] [Abstract][Full Text] [Related]
31. Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling.
Nakajima A; Yamakuni T; Matsuzaki K; Nakata N; Onozuka H; Yokosuka A; Sashida Y; Mimaki Y; Ohizumi Y
J Pharmacol Exp Ther; 2007 May; 321(2):784-90. PubMed ID: 17289833
[TBL] [Abstract][Full Text] [Related]
32. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
33. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
[TBL] [Abstract][Full Text] [Related]
34. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
35. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.
Billings LM; Oddo S; Green KN; McGaugh JL; LaFerla FM
Neuron; 2005 Mar; 45(5):675-88. PubMed ID: 15748844
[TBL] [Abstract][Full Text] [Related]
36. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J
Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818
[TBL] [Abstract][Full Text] [Related]
37. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
[TBL] [Abstract][Full Text] [Related]
38. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
[TBL] [Abstract][Full Text] [Related]
39. Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.
Poirier R; Wolfer DP; Welzl H; Tracy J; Galsworthy MJ; Nitsch RM; Mohajeri MH
Neurobiol Dis; 2006 Dec; 24(3):475-83. PubMed ID: 17008108
[TBL] [Abstract][Full Text] [Related]
40. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]